Literature DB >> 21360353

[A pilot study on the effectiveness of a group-based cognitive-behavioral therapy program for coping with auditory hallucinations].

Oya Mortan1, Serap Tekinsav Sütcü, Güzide German Köse.   

Abstract

OBJECTIVE: The aim of this study was to prepare a group-based cognitive-behavioral therapy program for patients with schizophrenia and other psychotic disorders coping with auditory hallucinations, and to evaluate the effectiveness of the program.
METHOD: The study included 12 male inpatients aged between 18 and 55 years from the Manisa Mental Health and Illnesses Hospital that were diagnosed with schizophrenia or schizoaffective disorder according to DSM-IV diagnostic criteria (SCID-I). The inclusion criteria were the diagnosis of schizophrenia or schizoaffective disorder, at least 1 hospitalization, the presence of auditory hallucinations, and the absence of alcohol/drug abuse/dependence, organic deficit, and mental/physical disability. In all, 7 patients received routine care plus group CBT and 5 patients received routine care alone. The group treatment program was conducted for 9-10 sessions twice a week. The patients were assessed using SAPS, SANS, the Problem/Symptom Checklist, and the Knowledge of Schizophrenia Questionnaire pre-treatment, post-treatment, and at the 1-year follow-up. The outcomes were analyzed using the Wilcoxon signed rank test.
RESULTS: There was a significant reduction in the severity and frequency of hallucinations, delusions, distress and occupation with auditory hallucinations, negative symptoms, and anxiety in the CBT group after treatment. Additionally, post-treatment outcome in the treatment group didn't change at 1 year follow-up. In the control group, there was no difference between pre-treatment and post-treatment outcome (P<0.05).
CONCLUSION: The therapy program was considered to be effective in increasing the ability to cope with auditory hallucinations and reducing their frequency for the patients with schizophrenia and schizoaffective disorder.

Entities:  

Mesh:

Year:  2011        PMID: 21360353

Source DB:  PubMed          Journal:  Turk Psikiyatri Derg        ISSN: 1300-2163


  7 in total

1.  Comparison of the Effectiveness of Two Cognitive-Behavioral Group Therapy Programs for Schizophrenia: Results of a Short-Term Randomized Control Trial.

Authors:  Oya Mortan Sevi; Serap Tekinsav Sutcu; Sema Yesilyurt; Sultan Turan Eroglu; Busra Gunes
Journal:  Community Ment Health J       Date:  2019-08-29

2.  Psychotherapy: Playing the Three Monkeys in Mental Health Service Provision?

Authors:  Çiğdem Dereboy; Hakan Şenel; Cennet Şafak Öztürk; Mehmet Şakiroğlu; Mehmet Eskin
Journal:  Noro Psikiyatr Ars       Date:  2017-12       Impact factor: 1.339

3.  Cognitive Behavioural Therapy for schizophrenia - outcomes for functioning, distress and quality of life: a meta-analysis.

Authors:  Keith R Laws; Nicole Darlington; Tejinder K Kondel; Peter J McKenna; Sameer Jauhar
Journal:  BMC Psychol       Date:  2018-07-17

4.  Cognitive-behavioural therapy for personal recovery of patients with schizophrenia: A systematic review and meta-analysis.

Authors:  Weiliang Wang; Yuqiu Zhou; Nannan Chai; Dongwei Liu
Journal:  Gen Psychiatr       Date:  2019-08-26

5.  Efficacy and durability of cognitive behavior therapy in managing hallucination in patients with schizophrenia.

Authors:  Priyanka Shukla; Debasish Padhi; K S Sengar; Abha Singh; Suprakash Chaudhury
Journal:  Ind Psychiatry J       Date:  2021-09-08

6.  Psychotic symptoms, functioning and coping in adolescents with mental illness.

Authors:  Johanna T W Wigman; Nina Devlin; Ian Kelleher; Aileen Murtagh; Michelle Harley; Anne Kehoe; Carol Fitzpatrick; Mary Cannon
Journal:  BMC Psychiatry       Date:  2014-04-01       Impact factor: 3.630

7.  Cognitive behavioural therapy for auditory hallucinations in schizophrenia: A review.

Authors:  Maria Pontillo; Franco De Crescenzo; Stefano Vicari; Maria Laura Pucciarini; Roberto Averna; Ornella Santonastaso; Marco Armando
Journal:  World J Psychiatry       Date:  2016-09-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.